4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one

C19H25N5O3 — CID 163622545

IUPAC4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one
SMILESCC[C@H]1O[C@@H](n2cc(C#CCN)c3c(N)ncnc32)C[C@H]1OCCC(C)=O
InChIInChI=1S/C19H25N5O3/c1-3-14-15(26-8-6-12(2)25)9-16(27-14)24-10-13(5-4-7-20)17-18(21)22-11-23-19(17)24/h10-11,14-16H,3,6-9,20H2,1-2H3,(H2,21,22,23)/t14-,15-,16-/m1/s1
InChIKeyJBSVLRCHBAATOT-BZUAXINKSA-N
MW371.44 g/mol
LogP1.39
Rot. Bonds6

About 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one

4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one (PubChem CID 163622545) has the molecular formula C19H25N5O3 and a molecular weight of 371.44 g/mol. Its IUPAC name is 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one.

Molecular Properties

Compound Name4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one
PubChem CID163622545
Molecular FormulaC19H25N5O3
Molecular Weight371.44 g/mol
Exact Mass371.20
IUPAC Name4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one
SMILESCC[C@H]1O[C@@H](n2cc(C#CCN)c3c(N)ncnc32)C[C@H]1OCCC(C)=O
InChIInChI=1S/C19H25N5O3/c1-3-14-15(26-8-6-12(2)25)9-16(27-14)24-10-13(5-4-7-20)17-18(21)22-11-23-19(17)24/h10-11,14-16H,3,6-9,20H2,1-2H3,(H2,21,22,23)/t14-,15-,16-/m1/s1
InChIKeyJBSVLRCHBAATOT-BZUAXINKSA-N
XLogP1.39
TPSA118.28 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500371.44
LogP ≤ 51.39
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one?
The IUPAC name of 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one (CID 163622545) is 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one.
What is the SMILES notation for 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one?
The canonical SMILES for 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one is CC[C@H]1O[C@@H](n2cc(C#CCN)c3c(N)ncnc32)C[C@H]1OCCC(C)=O.
What is the InChIKey of 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one?
The InChIKey is JBSVLRCHBAATOT-BZUAXINKSA-N. The full InChI is InChI=1S/C19H25N5O3/c1-3-14-15(26-8-6-12(2)25)9-16(27-14)24-10-13(5-4-7-20)17-18(21)22-11-23-19(17)24/h10-11,14-16H,3,6-9,20H2,1-2H3,(H2,21,22,23)/t14-,15-,16-/m1/s1.
What are the key properties of 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one?
4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one has a molecular weight of 371.44 g/mol, XLogP of 1.39, 6 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(2R,3R,5R)-5-[4-amino-5-(3-aminoprop-1-ynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-2-ethyloxolan-3-yl]oxybutan-2-one is sourced from PubChem (CID 163622545), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).